Back to search

Article

Diazoxide choline (Vykat XR) for treatment of hyperphagia and obesity in Prader-Willi syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

2026-08-01

Abstract excerpt

Prader-Willi syndrome (PWS) is a rare genetic disorder with an estimated incidence of 1 in 21,000 caused by the loss of function of specific genes on the paternal chromosome 15 (15q11-q13 region). It affects multiple systems and is characterized by distinctive dysmorphic features along with a set of clinical features that evolve over time. The phenotype was first described in 1956,1 and over time, the clinical spe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4e09d7b8-4d6e-5f7b-b529-c8ab12296dd2
DOI
10.1016/j.gimo.2026.104412
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Diazoxide choline (Vykat XR) for treatment of hyperphagia and obesity in Prader-Willi syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)DOI 10.1016/j.gimo.2026.104412
Select a neighboring publication to make it the new centre.